Browse > Article

Retrospective Drug Utilization Review Study on the Therapeutic Duplication in Patients with Anxiety Disorders  

Park, Chan-Hyun (College of Pharmacy, Sookmyung Women's University)
Sohn, Hyun-Soon (College of Pharmacy, Sookmyung Women's University)
Shin, Hyun-Taek (College of Pharmacy, Sookmyung Women's University)
Choi, Kyung-Eob (Health Insurance Review and Assessment Service (HIRA))
Publication Information
Korean Journal of Clinical Pharmacy / v.20, no.1, 2010 , pp. 39-49 More about this Journal
Abstract
The present study was aimed to examine the occurrence and influencing factors therapeutic duplication (TD) of medications for anxiety disorders by analyzing the relevant prescription data. In this study, the prescription data issued on March 19, 2008 in domestic medical institutes were utilized. TD was defined as more than two medications under the same therapeutic classification per prescription based on the Anatomical Therapeutic Classification (ATC) code. The assessment of TD was performed based on the number of cases and on the ratio determined. To identify the influencing factor of TD, the variables related to the differences in the TD ratio were analyzed based on the results of the Chi-Square test conducted with the variables; patients, medical institutes, diseases, and treatments. The number and ratio of TD were determined to be 1,333 out of the total of 19,219 anxiety disorder cases, and 6.94%, most cases involving benzodiazepine derivatives, respectively. The TD ratio was found to be higher in relation to males than to females. Patients with national health insurance benefits have a higher TD ratio compared to the medical-aid beneficiaries. The TD ratios were highest in clinics, psychiatry divisions, and Gyeongsang district. The TD ratio of the cases with more than two anxiety disorders was found to be higher than that of the cases with only one anxiety disorder. As the number of medications per prescription increased, the TD ratio was shown to have become gradually higher. In conclusion, in order to prevent TD, the concurrent DUR system should be implemented. The prescribers and pharmacists must be educated regarding duplicated medications to promote the safe and effective use of medicines, without unnecessary TD.
Keywords
therapeutic duplication; retrospective drug utilization review; DUR; anxiety disorder;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wagner AK, Zhang F, Soumerai SB, et al., Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004; 164(14): 1567-72.   DOI   ScienceOn
2 이지은 외. 복수과 진료 환자의 중복사용에 대한 분석 및 평가. 한국병원약사회지 2003; 20(1): 1-7.
3 강이경. 건강보험자료를 이용한 의원의 노인 처방 경향 및 적절성 평가. 숙명여자대학교 임상약학대학원 석사학위논문. 2006.
4 National Health Committee. Guidelines for Assessing and Treating Anxiety Disorder. 1998.
5 건강보험심사평가원 평가실. 처방전당 약품목수 평가결과공개. 2008년 1월 22일 보도자료.
6 Soumerai SB, Lipton HL. Computer-Based Drug-Utilization Review-Risk, Benefit, or Boondoggle. N Engl J Med 1995; 332: 1641-1645.   DOI   ScienceOn
7 The U.S. Pharmacopeia Drug Utilization Review Advisory Panel. Drug Utilization Review: Mechanisms to Improve Its Effectiveness and Broaden Its Scope. J Am Pharm Assoc 2000; 40(4): 538-545.
8 국민건강보험공단. 2004-2008년 불안장애 진료환자 현황. 2008.
9 김상미. 숙명여자대학교 일반대학원 석사학위논문. 2009.
10 보건복지부 예규 제130호. 의약품사용평가위원회에 관한 규정. 2003년 12월 3일.
11 한국약학대학협의회 약물학분과회. 약물학. 2005.
12 Meredith S, Feldman PH, Frey D, et al., Possible medication errors in home healthcare patients. Journal of the American Geriatrics Society. 2001; 49: 719-24.   DOI   ScienceOn
13 Schuler J, Duckelmann C, Beindl, W, et al., Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wiener Klinische Wocheschrift. 2008; 120(23-24): 733-41.   DOI   ScienceOn
14 Baldwin DS, Anderson IM, Nutt DJ, et al., British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of psychopharmacology. 2005; 19(6): 567-96.   DOI   ScienceOn
15 건강보험심사평가원. 동일 요양기관 동일 성분 의약품 중복사용 관리 지침. 2009년 5월.
16 Canadian Psychiatric Association. Clinical practice guidelines: management of anxiety disorders. Can J Psychiatry.2006; 51 Suppl 2.
17 Dipiro JT, Talbert RL, Yee GC, et al., Pharmacotherapy: a Pathophysiologic Approach 7th ed.
18 배성미. 각 약물의 Drug Use Evaluation에 의한 적정성 추구. J Kor Soc Health-Syst Pharm 2001; 18(4): 433-439.
19 Lyles A, Sleath B, Fulda TR, et al., Ambulatory Drug Utilization Review: Opportunities for Improved Prescription Drug Use. AJMC 2001; 7(1): 75-83.
20 의약품사용평가(DUR) 학술정보. 대한약사회 2004.